Related Experiment Video
Updated: Jun 27, 2026
11:30
Preparation and Characterization of Nanoliposomes for the Entrapment of Bioactive Hydrophilic Globular Proteins
Published on: August 31, 2019
[BFGF entraped in cationic liposomes as adjuvant: optimization of technical parameters]
Zhen-hua Zhong1, Shuang-lin Mao, Li Yang
1State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Summary
Cationic liposomes effectively encapsulate basic fibroblast growth factor (bFGF) and demonstrate strong immune efficiency as an adjuvant in vivo. This research highlights their potential as safe and effective immunological adjuvants.
Area of Science:
- Biotechnology
- Immunology
- Materials Science
Context:
- Adjuvants are critical for enhancing vaccine immunogenicity.
- Liposomes are versatile drug delivery systems with tunable properties.
- Basic fibroblast growth factor (bFGF) has potential immunomodulatory roles.
Purpose:
- To evaluate the immune efficiency of basic fibroblast growth factor (bFGF) encapsulated in cationic liposomes as an adjuvant.
- To optimize the encapsulation parameters for bFGF within cationic liposomes.
Summary:
- Technical parameters including lipid composition, protein-to-lipid ratio, extrusion, and freeze-thawing were optimized to achieve high encapsulation efficiencies (around 50%).
- Balb/c mice were immunized with bFGF in cationic liposomes, Freund's adjuvant, or PBS, with serum antibody levels measured by ELISA post-injection.
- Results indicated that cationic liposomes loaded with bFGF demonstrated significant immune efficiency.
Impact:
- Cationic liposomes serve as a safe and effective immunological adjuvant.
- This study provides a foundation for developing novel liposome-based vaccine formulations.
- Optimized liposomal encapsulation enhances the delivery and efficacy of therapeutic proteins.
